Hemagglutinin Antikörper (AA 350-400)

Produktnummer ABIN6992012

Der Kaninchen Polyklonal Anti-Hemagglutinin-Antikörper wurde für ELISA validiert. Er ist geeignet, Hemagglutinin in Proben von Influenza A Virus H7N9 zu detektieren.

Kurzübersicht für Hemagglutinin Antikörper (AA 350-400) (ABIN6992012)

Target: Hemagglutinin (HA)

Reaktivität: Influenza A Virus H7N9

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Hemagglutinin Antikörper ist unkonjugiert

Applikation: ELISA

Produktdetails anti-Hemagglutinin Antikörper

Bindungsspezifität: AA 350-400

Spezifität: Virus

Aufreinigung: Avian Influenza A H7N9 Hemagglutinin antibody is affinity chromatography purified via peptide column.

Immunogen: Avian Influenza A H7N9 Hemagglutinin antibody was raised against a synthetic peptide corresponding to 19 amino acids near the center of the H7N9 [Influenza A virus (A/Shanghai/02/2013(H7N9))] hemagglutinin protein. The immunogen is located within amino acids 350 - 400 of Avian Influenza A H7N9 Hemagglutinin.

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Avian Influenza A H7N9 Hemagglutinin antibody can be used for detection of Avian Influenza A H7N9 Hemagglutinin by ELISA at 1 μ,g/mL.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Konzentration: 1 mg/mL

Buffer: Avian Influenza A H7N9 Hemagglutinin Antibody is supplied in PBS containing 0.02 % sodium azide.

Konservierungsmittel: Sodium azide

Vorsichtsmaßnahmen: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,4 °C

Informationen zur Lagerung: Avian Influenza A H7N9 Hemagglutinin antibody can be stored at 4°C for three months and -20°C, stable for up to one year.

Details zu Hemagglutinin

Target: Hemagglutinin (HA)

Andere Bezeichnung: Avian Influenza A H7N9 Hemagglutinin

Substanzklasse: Influenza Protein

Hintergrund: Influenza A virus is a major public health threat, killing more than 30,000 people per year in the USA (1). Novel influenza virus strains caused by genetic drift and viral recombination emerge periodically to which humans have little or no immunity, resulting in devastating pandemics. Influenza A can exist in a variety of animals, however it is in birds that all subtypes can be found (2). These subtypes are classified based on the combination of the virus coat glycoproteins hemagglutinin (HA) and neuraminidase (NA) subtypes. H7N9 bird flu is the newest atypical influenza virus infection that has just been reported since early 2013. The emergence of this new strain occurred in China and has become the present focus for possible worldwide pandemic (3).

UniProt: R4NN21